Industry Information

Update June 10, 2021

The five-year compound growth rate is 9.2%! What are the opportunities in the natural anti-tumor drug market?

一. Basic information of taxane anti-tumor drugs Product description Paclitaxel (Paclitaxel, PTX) is a microtubule stabilizing drug that selectively inhibits the depolymerization of microtubules,...

Update June 08, 2021

According to the analysis of CDE drug review, 30 category 1 therapeutic biological products and 46 category 1 chemical drugs were accepted, Geli, Hausen...

According to the latest statistics of Yaozhi Data, in May 2021, CDE has undertaken a total of 820 new drug registration applications (except for re-examination, the same below), including 614...

Update June 07, 2021

Analysis of the "Top Three Top 100 Pharmaceutical Industry"! 2021 China's top 100 pharmaceutical R&D strengths will be released soon

Time has passed quietly, and 2021 is about to halfway through. Under the national strategy of "innovation-driven development", the innovative medicine industry is upgraded again, and people's demand...

Update June 05, 2021

The policy of the Medical Insurance Bureau is outrageous! A large number of drugs such as Pfizer, AZ, and Harbin Pharmaceuticals have been removed from the Internet

On December 25, 2020, the Office of the National Medical Security Administration issued the "Notice on Accelerating the Implementation of the Pharmaceutical Price and Recruitment Credit Evaluation...

Update June 04, 2021

Qilu, Hengrui, CSPC... 83 varieties have been reviewed! 16 varieties were the first to be reviewed, and a variety of blockbuster injections entered the centralized procurement

According to the consistency evaluation analysis system of Yaozhi Data Enterprise Edition, 74 new consistency evaluation acceptance numbers were added in May 2021; 157 approvals (including 38 deemed...

Update June 03, 2021

"Tumor treatment shady" punishment result is here! Where will cell therapy go?

On May 28, the official website of the Supervision Office of the Shanghai Municipal Health Commission announced the relevant punishment results of Lu Wei, the doctor involved in the "tumor treatment...

Update June 02, 2021

Nature: reactivating the paralyzed immune system to attack fatal brain cancer

Glioma is the most common primary central nervous system tumor. Because it has no obvious boundary with normal brain tissue, it is difficult to completely remove. Therefore, it is not very sensitive...

Update June 01, 2021

New double-anti-ADC and ADC players enter the game, and financing companies "challenge" leading position in May

According to incomplete statistics, as of May 31, 54 financing incidents (excluding IPOs, mergers and acquisitions, equity financing, private placement and strategic investment) occurred in the...

Update May 31, 2021

Innovative drugs, vaccines, CDMO, and the IPOs of major new players in the pharmaceutical industry this Wednesday, who is more powerful?

"Innovation", as the main driving force of the biomedical industry in recent years, has forced the industry to actively seek technological and model advancement. Especially after the "new crown...

Update May 28, 2021

Hu Yunfu: Strategies and Trends of Drug Clinical Companion Diagnosis in New Drug Development

In the past few years, the proportion of targeted drugs in the new drug projects approved by the US FDA has gradually increased, from the common EGFR to the rare NTRK. Dr. Hu Yunfu said: "Companion...